Key Takeaways
- The S&P 500 slipped lower than 0.1% on Friday, Might 30, 2025, as President Trump rekindled his powerful rhetoric on China and a key report revealed softening inflation.
- Regeneron Prescribed drugs shares plummeted after the corporate’s experimental COPD remedy fell wanting expectations in a late-stage medical trial.
- Make-up vendor Ulta Magnificence reported better-than-expected quarterly gross sales and income, and its shares surged.
Main U.S. equities indexes had been combined within the last session of the holiday-shortened buying and selling week as President Donald Trump reverted to an antagonistic tone on commerce with China and the newest Private Consumption Expenditures information confirmed that inflation fell greater than anticipated in April.
The S&P 500 staged a Friday-afternoon rally, getting back from deeper in unfavourable territory to finish with a lack of lower than 0.1%. The Nasdaq was down 0.3%, whereas the Dow held onto a achieve of 0.1%. The Nasdaq and S&P logged their strongest months since 2023. Learn Investopedia’s full protection of at present’s buying and selling right here.
Shares of Regeneron Prescribed drugs (REGN) plunged 19%, dropping essentially the most of any inventory within the S&P 500. The losses got here after an experimental remedy for persistent obstructive pulmonary illness in former people who smoke, developed by Regeneron in collaboration with Sanofi (SNY), failed to satisfy major endpoints in a Part 3 trial. The businesses mentioned they’re reviewing the information and can work with regulators to stipulate potential subsequent steps. U.S.-listed shares of Sanofi slid 5.7%.
Cooper Cos. (COO)Â shares dropped 15% after the contact lens producer lowered its full-year outlook for natural progress whereas edging out consensus gross sales and adjusted revenue estimates with its fiscal second-quarter outcomes. Analysts at JPMorgan downgraded Cooper inventory to “impartial” from “obese,” citing the corporate’s uneven execution and the opportunity of a sustained slowdown in market traits.
Shares of Eastman Chemical (EMN), recognized for its specialty plastics and adhesives, fell 3.8%. The corporate introduced that its molecular recycling mission in Longview, Texas, which was beforehand anticipated to obtain $375 million in public funding, was amongst 24 awards revoked by the Division of Vitality.
Cosmetics retailer Ulta Magnificence (ULTA) topped gross sales and revenue estimates for its fiscal first quarter and lifted its outlook for the complete yr. CEO Kecia Steelman highlighted contributions from new and unique manufacturers in addition to sturdy gross sales of perfume merchandise, noting that buyers had been turning to magnificence merchandise “as a consolation and escape from the stress of macro uncertainty.” Ulta shares skyrocketed 12%, scoring the S&P 500’s prime every day efficiency.
Shares of Palantir Applied sciences (PLTR) jumped 7.7% as a New York Instances report indicated that the Trump administration has expanded the information analytics software program agency’s position in authorities data-sharing initiatives. The tech firm, which has profitable contracts with the federal authorities and Protection Division, is reportedly engaged in efforts to enhance entry to information throughout authorities companies.
Enphase Vitality (ENPH)Â inventory superior 5.5%. Shares of the photo voltaic microinverter producer got here underneath heavy strain alongside different renewable power gamers after the Home of Representatives handed a tax and spending invoice that might get rid of sure incentives for clear power tasks, together with a federal tax credit score for the set up of photo voltaic rooftop techniques. Enphase Vitality shares dropped to a 52-week low on Might 22, the day the invoice was handed, however have staged a partial restoration since.
Costco Wholesale (COST) inventory added 3.1% after the majority retailer’s quarterly income and internet revenue edged out consensus forecasts. Similar-store gross sales additionally grew greater than anticipated. Analysts have advised that high-margin membership income may present Costco with some flexibility to navigate tariff-related value strain with out elevating costs.